Quintiles Transitional Holdings Inc. (NYSE:Q)‘s stock had its “hold” rating reaffirmed by research analysts at Jefferies Group LLC in a research report issued on Friday. They currently have a $94.00 target price on the medical research company’s stock. Jefferies Group LLC’s target price would indicate a potential upside of 3.96% from the stock’s previous close.

Q has been the topic of several other research reports. Barclays PLC upped their target price on Quintiles Transitional Holdings from $98.00 to $100.00 and gave the stock an “overweight” rating in a report on Friday. Zacks Investment Research lowered Quintiles Transitional Holdings from a “buy” rating to a “hold” rating in a report on Tuesday. William Blair upgraded Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $70.10 to $93.42 in a report on Friday. Evercore ISI reiterated an “in-line” rating and set a $88.50 target price (up previously from $84.00) on shares of Quintiles Transitional Holdings in a report on Thursday, May 4th. Finally, Mizuho upped their target price on Quintiles Transitional Holdings from $90.00 to $93.00 and gave the stock a “buy” rating in a report on Thursday, May 4th. Eleven equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $89.41.

Quintiles Transitional Holdings (NYSE:Q) opened at 90.42 on Friday. The stock’s 50 day moving average price is $89.50 and its 200-day moving average price is $82.85. The firm has a market cap of $19.90 billion, a price-to-earnings ratio of 200.04 and a beta of 0.64. Quintiles Transitional Holdings has a one year low of $70.10 and a one year high of $93.53.

Quintiles Transitional Holdings (NYSE:Q) last issued its quarterly earnings results on Thursday, August 3rd. The medical research company reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.04. The company had revenue of $1.97 billion for the quarter, compared to analyst estimates of $1.96 billion. Quintiles Transitional Holdings had a return on equity of 15.68% and a net margin of 0.82%. The company’s quarterly revenue was up 68.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.93 earnings per share. Analysts forecast that Quintiles Transitional Holdings will post $4.55 earnings per share for the current year.

Quintiles Transitional Holdings declared that its board has approved a stock repurchase plan on Wednesday, May 24th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the medical research company to buy up to 5.4% of its shares through open market purchases. Shares repurchase plans are usually a sign that the company’s management believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: “Quintiles Transitional Holdings Inc. (Q) Given “Hold” Rating at Jefferies Group LLC” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another site, it was copied illegally and reposted in violation of U.S. & international copyright laws. The correct version of this article can be accessed at https://www.dailypolitical.com/2017/08/05/quintiles-transitional-holdings-inc-q-given-hold-rating-at-jefferies-group-llc.html.

In other news, Director Jack M. Greenberg sold 6,092 shares of the company’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $82.50, for a total value of $502,590.00. Following the transaction, the director now owns 2,930 shares of the company’s stock, valued at $241,725. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director John G. Danhakl sold 761,143 shares of the company’s stock in a transaction that occurred on Tuesday, May 30th. The shares were sold at an average price of $84.01, for a total value of $63,943,623.43. The disclosure for this sale can be found here. Insiders sold 8,758,400 shares of company stock worth $735,783,985 in the last ninety days. 6.40% of the stock is owned by company insiders.

Several institutional investors have recently bought and sold shares of Q. Korea Investment CORP increased its position in Quintiles Transitional Holdings by 142.5% in the second quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock valued at $123,000 after buying an additional 805 shares during the last quarter. Global X Management Co. LLC increased its position in Quintiles Transitional Holdings by 30.8% in the first quarter. Global X Management Co. LLC now owns 1,469 shares of the medical research company’s stock valued at $118,000 after buying an additional 346 shares during the last quarter. IFP Advisors Inc increased its position in Quintiles Transitional Holdings by 187.1% in the first quarter. IFP Advisors Inc now owns 1,774 shares of the medical research company’s stock valued at $143,000 after buying an additional 1,156 shares during the last quarter. Archford Capital Strategies LLC purchased a new position in Quintiles Transitional Holdings during the first quarter valued at approximately $160,000. Finally, Bbva Compass Bancshares Inc. purchased a new position in Quintiles Transitional Holdings during the first quarter valued at approximately $170,000. 92.47% of the stock is currently owned by institutional investors.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Analyst Recommendations for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.